Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Abstract: Variances in global access to drugs and treatment practices make it challenging to understand the benefit of contemporary therapies in patients with relapsed and refractory (R/R) mature T-cell and natural killer–cell lymphomas (MTCL and MNKCL). We conducted an international retrospective c...
Saved in:
Similar Items
-
Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas
by: Josie G. Ford, et al.
Published: (2025-08-01) -
SynC2S: An Efficient Method for Synthesizing Tabular Data With a Learnable Pre-Processing
by: Jiwoo Kim, et al.
Published: (2025-01-01) -
Les Anglais en France : sensualisme pérégrin et écriture du voyage dans la première moitié du xviiie siècle
by: Antoine Eche
Published: (2010-07-01) -
The unseen carbon: Scope 3 emissions transform understanding of electricity generation in import-dependent nations
by: Seokju Kim, et al.
Published: (2025-02-01) -
P721: Functional analysis of two JAG1 missense variants in Alagille syndrome
by: Jiyoung Oh, et al.
Published: (2025-01-01)